Business / Finance

RSS

Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates

A new robotics platform was inaugurated at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) on Thursday, June 15, 2023, in the presence of Thuringia's State Secretary for Research, Innovation and Economic Development.

From Analytik Jena AG 23 Jun 2023

Introducing CELLER8®: Revolutionising Wellness with PEMF Technology

Med-tech manufacturer, Bedfont® Scientific Ltd., launches new CELLER8® PEMF device with exclusive distributor, NewMed Ltd. at the Health Optimisation Summit 2023.

From Bedfont® Scientific Ltd 22 Jun 2023

INTEGRA Biosciences’ pipettes help to advance cancer drug discovery

The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows.

From INTEGRA Biosciences 20 Jun 2023

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.

From Closed Loop Medicine 20 Jun 2023

H.E.L Group expands into new purpose-designed facilities

Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers.

From H.E.L Group 20 Jun 2023

Sphere Fluidics’ Pico-Mine platform chosen by Biosyntia to accelerate synthetic biology and metabolic workflows

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactive.

From Sphere Fluidics 20 Jun 2023

Catalent expands OneBio® suite for integrated development, manufacturing and supply across biologic modalities

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

From Catalent 16 Jun 2023

Complete genomics announces updated mission and new partnerships on 18th anniversary

Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

From MGI 15 Jun 2023

Cerillo showcases wireless, scalable, off-the-shelf co-culture solution

Cerillo, a biotechnology company at the forefront of developing advanced research platforms for the study of the microbiome, will host demonstrations of the company’s new co-culture duet system at ASM Microbe 2023 from June 16-18th in Houston, Texas at booth #704.

From Cerillo 15 Jun 2023

Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

From Charles Rivers Laboratories Cell and Gene Therapy 13 Jun 2023

Axol Bioscience collaborates with StrataStem to deliver stem cell based ‘clinical trial in a dish’ for Alzheimer’s disease

Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease (AD) patient samples.

From Axol Bioscience Ltd 7 Jun 2023

INTEGRA Biosciences’ pipettes help to combat prostate cancer

The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment.

From INTEGRA Biosciences 6 Jun 2023

ESPG AG publishes annual report 2022 and looks back on successful year

ESPG AG, a real estate company specialising in science parks, today published its audited annual financial statements for 2022, which have been issued with an unqualified audit opinion by the auditor.

From The European Science Park Group (ESPG) 6 Jun 2023

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

REPROCELL today announces the launch of a new commercial service, Pharmacology-AI.

From REPROCELL 2 Jun 2023

ESPG extends lease with anchor tenant in Science Park “Lab City” until 2033

The European Science Park Group, a real estate company specialising in science parks, has extended the lease agreement with the anchor tenant of the Science Park “Lab City” in Neu-Ulm until 31 December 2033.

From The European Science Park Group (ESPG) 2 Jun 2023

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

eMolecules acquires Specs Compound Handling B.V.

Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers.

From eMolecules 26 May 2023

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Researchers can now order their mutation of choice in bit.bio’s opti-oxTM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated into drug discovery workflows.

From bit.bio 24 May 2023

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

A collaborative agreement between Izon Science and Agarose Bead Technologies (ABT) offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

From Agarose Bead Technologies 16 May 2023

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Affordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities.

From Bruker Cellular Analysis 16 May 2023